Xenon Pharmaceuticals (XENE) PT Raised to $8 at Jefferies Following New Epilepsy Asset

May 10, 2017 10:35 AM

Jefferies raised its price target on Xenon Pharmaceuticals (NASDAQ: XENE) to ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found